Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab

Protein Cell. 2018 Jan;9(1):135-139. doi: 10.1007/s13238-017-0412-8.

Shuguang Tan¹, Kefang Liu^{2

3}, Yan Chai¹, Catherine W-H Zhang⁴, Shan Gao⁵, George F Gao^{1

2

3}, Jianxun Qi⁶

¹ CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
² National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, 102206, China.
³ College of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, 325035, China.
⁴ ImmuFuCell Biotechnology Co.Ltd., Beijing, 100102, China.
⁵ CAS Key Laboratory of Bio-medical Diagnostic, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China.
⁶ CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China. [email protected].

No abstract available

Publication types